From illuminating public buildings in red to candlelight vigils and walks, supporters are gearing up to raise awareness and increase…
Andrea Lobo, PhD
Andrea Lobo holds a PhD in cell biology/neurosciences from the University of Coimbra-Portugal, where she studied stroke biology. As a research scientist for 19 years, Andrea participated in academic projects in multiple research fields, from stroke, gene regulation, cancer, and rare diseases. She has authored multiple research papers in peer-reviewed journals.
At Bionews we’re committed to providing the most accurate, relevant, and up-to-date reporting for our patient communities. Our goal is to ensure that everyone has access to disease-specific information that is both trustworthy and easy to understand. You can read more about our editorial policy here.
Articles by Andrea Lobo, PhD
Meningitis — an inflammation of the protective membranes surrounding the brain and spinal cord — remains associated with a case-fatality…
Top-line data from the Phase 3 part of RISE UP, a clinical trial testing mitapivat in people with sickle…
The use of computed tomography pulmonary angiography (CTPA) to assess the presence of blood clots in lung blood vessels increased…
More perceived social support from classmates is associated with less disease severity among children and adolescents with sickle cell anemia,…
A toolkit may facilitate the active involvement of parents of young children with sickle cell disease (SCD) in shared…
Hydroxyurea may effectively reduce the risk of stroke in children with sickle cell disease (SCD), a systematic review…
A scientist at Florida Atlantic University, Sarah E. Du, has been named a senior member of the U.S. National Academy…
Some children with sickle cell disease (SCD) may benefit from supplementing with folic acid, according to a clinical trial.
Vertex Pharmaceuticals has entered a reimbursement agreement with the National Health Service in England that will enable eligible…